Brimonidine gel
Indication
Symptomatic treatment of moderate to severe facial erythema of rosacea in adult patients
Green (Restricted)
Brand:
Mirvaso®
Nice TA:
Commissioning responsibility:
CCG (HRG included)
PbR excluded:
No
BNF chapter:
Skin
Background
Restriction:
For use in patients with moderate to severe, persistent facial erythema of rosacea
Recommendation
LSCMMG Recommendation:
Green (Restricted)
Reason for decision:
Suitable for initiation in primary care in line with restrictions
Supporting documents: